In a meeting with the Prime Minister, Kyriakos Mitsotakis, at the Maximos Palace, Charles Dallara, Chairman of the Board, Partners Group USA, Thomas Werner, President of the Supervisory BoD, Pharmathen and Dimitris Kadis, CEO of Pharmathen, on Friday 8 In April, they announced an additional € 50 million aid to Pharmathen’s € 200 million investment program, which is already under way for the five years 2022-2026.
Pharmathen, one of the leading pharmaceutical companies in Europe and a leader in the field of extended release compound injection products (LAI), has the new resources of 50 million in the creation of a new innovation hub in Attica that will be completed in 2025. According to the relevant announcement , the investment will build on Pharmathen’s experience in injectable prolonged-release products as well as ophthalmic technologies, enhancing the company’s competitive edge in the international pharmaceutical market, and creating at least 150 new jobs.
The design and construction of the new Pharmathen unit is based on the strict specifications of the EMA (European Medicines Agency) and the FDA (American Medicines Agency). Pharmathen already has two modern production units in Pallini, Attica and in Sapes, Rodopi and is the largest private investor in Research and Development in Greece and one of the largest in Europe.
Faithful to the implementation of its development plan, part of which was the 250 million euros invested during the five years 2015-2021 creating 450 new jobs, Pharmathen plans to offer a total of 700 new jobs over the next five years.
Dimitris Kadis, CEO of Pharmathen, said: “The increase of our investment plan by 50 million euros, proves in practice the confidence of the management and the shareholders of the company in the excellent scientific potential of the country. We remain committed to the production of innovation “Together we invest in new technologies and products. Together with our team of 1,200 employees, we give our best every day to improve the lives of millions of people around the world.”
Source: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
